Malignant triton tumor of the head and neck: A case report and review of the literature

Head Neck. 1999 Oct;21(7):663-70. doi: 10.1002/(sici)1097-0347(199910)21:7<663::aid-hed12>3.0.co;2-4.

Abstract

Background: Malignant triton tumor (MTT) is a relatively rare, aggressive tumor comprised of both malignant schwannoma cells and malignant rhabdomyoblasts. Because MTT frequently arises in the head and neck, the otolaryngologist must be aware of the nature of the tumor and its response to various treatment modalities.

Method: This article reviews the treatment and outcome of all reported cases of MTT arising in the head and neck.

Conclusions: Although statistical analysis is limited by the short duration of follow-up of many patients, complete tumor resection appears to carry an improved chance of survival. Adjuvant radiation and chemotherapy may also improve survival, although a benefit of these therapies was not well demonstrated in this small series.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biopsy, Needle
  • Child
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Etoposide / administration & dosage
  • Fatal Outcome
  • Female
  • Head and Neck Neoplasms / diagnosis
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Ifosfamide / administration & dosage
  • Lung Neoplasms / secondary
  • Magnetic Resonance Imaging
  • Mesna / administration & dosage
  • Neoplasm Recurrence, Local
  • Neurilemmoma / diagnosis
  • Neurilemmoma / pathology
  • Neurilemmoma / secondary
  • Neurilemmoma / therapy*
  • Radiotherapy Dosage
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Etoposide
  • Cyclophosphamide
  • Mesna
  • Cisplatin
  • Ifosfamide